THYROSEQ Trademark

Trademark Overview

On Thursday, December 12, 2013, a trademark application was filed for THYROSEQ with the United States Patent and Trademark Office. The USPTO has given the THYROSEQ trademark a serial number of 86141903. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, August 13, 2024. This trademark is owned by UPMC. The THYROSEQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical testing services, namely, next generation sequencing test for diagnosis and treatment of thyroid cancer and thyroid nodules
thyroseq

General Information

Serial Number86141903
Word MarkTHYROSEQ
Filing DateThursday, December 12, 2013
Status800 - REGISTERED AND RENEWED
Status DateTuesday, August 13, 2024
Registration Number4568245
Registration DateTuesday, July 15, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Pseudo MarkTHYRO SEQ; THYROID SEQUENCING
Goods and Servicesmedical testing services, namely, next generation sequencing test for diagnosis and treatment of thyroid cancer and thyroid nodules

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 27, 2013
Primary Code044
First Use Anywhere DateMonday, August 26, 2013
First Use In Commerce DateTuesday, October 1, 2013

Trademark Owner History

Party NameUPMC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219
Party NameUPMC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219
Party NameUPMC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219

Trademark Events

Event DateEvent Description
Friday, December 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 16, 2013NEW APPLICATION ENTERED
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 15, 2014REGISTERED-PRINCIPAL REGISTER
Saturday, December 28, 2013NOTICE OF PSEUDO MARK E-MAILED
Friday, March 21, 2014ASSIGNED TO EXAMINER
Saturday, March 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Monday, July 15, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 24, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, September 19, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Saturday, January 16, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, November 14, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, November 17, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, January 27, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 27, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 28, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, August 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 13, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, August 13, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, August 13, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, July 15, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

thyroseq thyroid treatment diagnosis cancer nodules test sequencing services testing namely